Nest.Bio Ventures
Nest.Bio Ventures operates a Cambridge-area biotech startup ecosystem combining BSL2+ shared/private lab facilities (Nest.Bio Labs and Hatch.Bio Labs) with an active venture arm that takes a cross-border approach to funding and commercializing breakthrough life sciences companies.
- Company typePrivate
- Founded2016
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Nest.Bio Ventures does
Nest.Bio Ventures operates a biotech startup ecosystem in the Cambridge-Kendall Square corridor, comprising three interconnected offerings: Nest.Bio Labs, Hatch.Bio Labs, and the Nest.Bio Ventures investment arm. Nest.Bio Labs, founded in 2018 and headquartered at 100 Chestnut Street in Somerville, MA, provides BSL2+ certified shared and private laboratory space, office space, and shared equipment infrastructure (thermocyclers, qRT-PCR, plate readers, biosafety cabinets, centrifuges, microscopes, vivarium) to early-stage life sciences companies on flexible monthly subscription terms with no equity requirements. Hatch.Bio Labs, launched in 2024 as the next-generation expansion, adds private lab suites and amenity-rich space in a new Somerville facility. The Ventures arm takes a cross-border (North America/Asia) active-investment approach, partnering with pioneering founders to develop, fund, and commercialize ground-breaking biotech technologies in therapeutics, immunotherapy, synthetic biology, and precision medicine.
The company's revenue model combines recurring subscription income from lab and office rentals with venture equity participation in portfolio companies. Resident and graduate companies span diverse applications — glycopolymers (Fount Bio), HIV CAR-T therapy (IT Bio), sewage epidemiology (Biobot Analytics), single-cell drug discovery (HiFiBiO), genome editing (EdiGene), autophagy therapeutics (PAQ Therapeutics), Alzheimer's therapeutics (iNeuro Therapeutics), and biosensors (BioSens8). Go-to-market relies on organic community-building within the Cambridge/MIT/Harvard biotech ecosystem, supported by content marketing (Scientist Spotlight blog series), monthly community events, Lunch & Learn sessions with partners like MassBio (Edge Program partnership established May 2024), and direct site tours.
Nest.Bio reports scale metrics of 50+ resident and graduate companies, 1,029+ local jobs created by resident companies, >$7B in combined market cap value of alumni and residents, and >$2.5B collectively raised by alumni companies over 7 years. Leadership is led by James Weis (Partner, CEO of Nest.Bio Labs and Hatch.Bio Labs), with partners including Cheryl Cui and Daphne Teo (also CEO of NSG BioLabs), supported by venture partners, advisors (including Tim Lu), and operational staff. Ownership and cap table details are not publicly disclosed. The company is privately held with 11-50 employees and no disclosed funding rounds for the parent entity.
Nest.Bio Ventures firmographics
Firmographics- Name
- Nest.Bio Ventures
- Legal name
- Nest.Bio Labs
- Website
- https://nest.bio
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nest.Bio Ventures operates a Cambridge-area biotech startup ecosystem combining BSL2+ shared/private lab facilities (Nest.Bio Labs and Hatch.Bio Labs) with an active venture arm that takes a cross-border approach to funding and commercializing breakthrough life sciences companies.
- Ownership category
- akta.pro rank
Nest.Bio Ventures industry classification
Industry- Product category
- Biotech Incubator Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Investment Advice (6282), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Nest.Bio Ventures is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Nest.Bio Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Laboratory Space Rental: Flexible leasing of shared and private BSL2+ laboratory bench space and wet lab suites to biotech startups. Revenue generated through monthly rental fees with flexible terms including single bench options to fully private suites.
- Office Space Rental: Flexible office space leasing including open plan desks, private offices, and semi-private office neighborhoods. Amenities included such as reception services, conference rooms, and fully-equipped kitchens.
- Venture Investment Returns: Active investment philosophy working alongside founding teams to translate high-impact science into therapies. Returns generated through equity participation in portfolio companies.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Nest.Bio Ventures product offering
Product offeringCore offering
Nest.Bio Ventures operates a biotech incubator ecosystem that provides shared and private BSL2+ laboratory and office space with flexible leasing (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville area. The company also runs a venture partnership program that invests in and supports pioneering biotech founders, helping develop, fund, and commercialize breakthrough technologies across therapeutics, diagnostics, and synthetic biology.
Product overview
Nest.Bio Ventures operates as a unified biotech ecosystem comprising three interconnected offerings: Nest.Bio Labs provides shared and private laboratory and office space for life science startups with flexible leasing and no equity requirements; Hatch.Bio Labs represents the next-generation facility expansion with private lab suites in a new Somerville location; and Nest.Bio Ventures delivers venture funding and partnership services to help develop, fund, and commercialize groundbreaking technologies. Together, these offerings support emerging biotech startups from early-stage research through commercialization, providing physical infrastructure, community, and capital.
Differentiator
Problem solved
Functional benefit
Products and services
- Nest.Bio Labs (Shared and Private Lab & Office Space) Shared and private BSL2+ certified laboratory and office space rented on flexible monthly terms (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville biotech ecosystem. Includes shared equipment (thermocyclers, qRT-PCR, plate reader/washer, biosafety cabinets, incubators, microscopes, autoclave, fume hoods), vivarium, reception, conference rooms, kitchens, EHS training, lab permits, and chemical/biohazard waste removal.
- Hatch.Bio Labs (Next-Generation Private Lab Facility) Next-generation private lab and office facility in Somerville, MA, offering BSL-2+ lab suites and flexible options from a single bench to fully private wet lab suites, with adjacent in-suite lab support rooms, board room, event space, reception, coffee shop, and cafe. Targets biotech startups seeking more dedicated lab environments while remaining in the Kendall Square ecosystem.
- Nest.Bio Ventures (Venture Partnership Program) Active venture partnership program that works alongside pioneering biotech founders to develop, fund, and commercialize groundbreaking technologies, leveraging the firm's on-site support at the shared lab facilities. Bridges North America and Asia through cross-border company creation and draws on partners' expertise in machine learning, immunotherapy, and synthetic biology.
Quantifiable outcome
- 50+ companies in resident and graduate community
- +3 more outcomes
Companies that use Nest.Bio Ventures
Customer profileNamed customers14 records
Segments3 records
Ideal customer profiles2 records
Nest.Bio Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Nest.Bio Ventures partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MassBiocoreMassBio partnership provides Nest.Bio residents access to valuable networking events, extensive discounts with top vendors, and essential resources through the MassBio Edge Program. Nest.Bio hosts Lunch & Learn sessions with MassBio representatives to help resident biotech researchers access these benefits. Representatives Paul Cosgro and Callahan Johnson assist residents in finding resources.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
Nest.Bio Ventures competitors and assessment
Company assessmentDirect peers
- LabCentral: Cambridge, MA-based shared laboratory and office space provider for early-stage biotech startups, operating BSL-2 facilities in Kendall Square. Most direct geographic and product competitor to Nest.Bio Labs.
- BioLabs: Operator of a national network of shared co-working lab facilities serving biotech startups across multiple US and European cities. Closest multi-site comparable to Nest.Bio/Hatch.Bio's lab-as-a-service model.
- SmartLabs: Provider of managed research environments combining core facility services with lab operations support for biotech tenants. Comparable in delivering turnkey lab infrastructure for resident companies.
- MBC BioLabs: San Carlos, CA-based shared lab and office space provider purpose-built for early-stage life sciences startups. Directly comparable in target customer and rental product offering.
- NSG BioLabs: Asia-focused biotech incubator and shared lab operator; led by Daphne Teo, who is also a Partner at Nest.Bio Ventures. Highly comparable operating model with explicit US-Asia linkage.
Emerging players
- IndieBio: Biotech-specific accelerator that takes equity and provides lab access, programming, and seed funding to early-stage biology startups. Comparable venture-adjacent incubator model with stronger investor-driven orientation.
- Petri (Petri.bio): Biotech accelerator and founder community that funds and supports early-stage life sciences startups. Comparable founder-support and community emphasis but with stronger venture funding orientation.
Broad incumbents
- JLABS (Johnson & Johnson Innovation): Johnson & Johnson-operated global network of life sciences incubators offering no-strings-attached lab space to early-stage biotech startups. Directly comparable no-equity incubator model at much larger scale.
- Cambridge Innovation Center (CIC): Large shared office and lab space operator in Kendall Square/Cambridge offering flexible memberships to startups across multiple sectors. Overlaps with Nest.Bio's office rental and broader community positioning.
- Alexandria LaunchLabs: Alexandria Real Estate's startup incubator arm offering shared lab and office space in major biotech clusters. Comparable product but backed by a much larger publicly traded REIT.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Nest.Bio Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nest.Bio Ventures leadership team
Management profileNumber of profiles
Profiles9 records
Nest.Bio Ventures subsidiaries and ownership
Company hierarchySubsidiaries1 record
Nest.Bio Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nest.Bio Ventures M&A and investment
M&A and investmentM&A
Investments19 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nest.Bio Ventures
What does Nest.Bio Ventures do?
Nest.Bio Ventures operates a biotech incubator ecosystem that provides shared and private BSL2+ laboratory and office space with flexible leasing (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville area. The company also runs a venture partnership program that invests in and supports pioneering biotech founders, helping develop, fund, and commercialize breakthrough technologies across therapeutics, diagnostics, and synthetic biology.
Is Nest.Bio Ventures a public or private company?
Nest.Bio Ventures is a private company. It is classified as venture growth investor backed and is currently operating.
When was Nest.Bio Ventures founded?
Nest.Bio Ventures was founded in 2016. It employs 11 to 50 people.
Where is Nest.Bio Ventures based?
Nest.Bio Ventures is headquartered in Boston, United States, in the North America region.
How does Nest.Bio Ventures make money?
Three revenue lines are on record. Laboratory Space Rental is the primary driver. The others are office Space Rental and venture Investment Returns.
Who are Nest.Bio Ventures's main competitors?
Direct peers on record are LabCentral, BioLabs, SmartLabs, MBC BioLabs and NSG BioLabs. Emerging players are IndieBio and Petri (Petri.bio). Broad incumbents are JLABS (Johnson & Johnson Innovation), Cambridge Innovation Center (CIC) and Alexandria LaunchLabs.
Does Nest.Bio Ventures have an API?
No public API is recorded for Nest.Bio Ventures.
What industry is Nest.Bio Ventures in?
Nest.Bio Ventures's product category is Biotech Incubator Services. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 541714 and its SIC code is 6282.